HBI Deals+Insights / M&A/IPOs
The sale of global dialysis provider Diaverum has officially launched with first-round bids submitted earlier this month, HBI hears, and second-round offers expected in the next few weeks. Who has actually bid is much less clear, however, and owner Bridgepoint is keeping the IPO option open.